FDA clarifies existing guidance on medical-device appeals

05/17/2013 | MassDevice.com (Boston)

Draft guidance issued by the FDA aims to explain its existing guidelines for medtech companies seeking to appeal the regulatory actions and decisions of the agency's device center. The proposal is up for comment for 90 days and will be added as an appendix to the FDA's current appeals guidance when finalized.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA